Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Plasmacytoma × Drug Combinations × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Rectal Neoplasms 1 Plasmacytoma 1 Neoplasm Metastasis 1 Margins of Excision 1 Homologous Recombination Deficient Solid Tumors 1 Drug-Related Side Effects and Adverse Reactions 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Radiotherapy 2 Lenalidomide 2 Dexamethasone 2 pomalidomide 1 ixazomib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 cc-486 1 auricularum 1 Thalidomide 1 Sodium Selenite 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Melphalan 1 Immunotherapy, Adoptive 1 Gemcitabine 1 Drug Combinations 1 Calcium Dobesilate 1 Busulfan 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04065308 2019-08-22

Dara_DCEP

Seoul National University Hospital

Phase 2 Unknown

Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡